• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4634701)   Today's Articles (2243)   Subscriber (49996)
For: Beutler E. Consensus recommendations. Br J Haematol 2007;138:673-5. [PMID: 17655726 DOI: 10.1111/j.1365-2141.2007.06716.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Number Cited by Other Article(s)
1
Ferritinemia during type 1 Gaucher disease: Mechanisms and progression under treatment. Blood Cells Mol Dis 2012;49:53-7. [DOI: 10.1016/j.bcmd.2012.04.002] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2011] [Accepted: 04/04/2012] [Indexed: 12/18/2022]
2
Beutler E. A vision of the future for Ph.D. graduates in science: A commencement address. Blood Cells Mol Dis 2008. [DOI: 10.1016/j.bcmd.2008.05.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
3
Zimran A, Elstein D. No justification for very high-dose enzyme therapy for patients with type III Gaucher disease. J Inherit Metab Dis 2007;30:843-4. [PMID: 18008181 DOI: 10.1007/s10545-007-0783-8] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA